This article is more than 5 years old. Information may no longer be current.

Regenexx issued US patent for stem cell procedure used to treat orthopedic conditions

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Regenexx recently announced its receipt of a U.S. patent for a same-day stem cell procedure used in the treatment of spine pain, joint injuries and degenerative orthopedic conditions.

According to a press release, the proprietary procedure uses an inflammatory agent to promote cartilage repair by stem cells.

“Consider this a patent on the use of a ‘till the soil’ injection before you plant the seeds (stem cells),” Christopher Centeno, MD, chief executive officer of Regenexx, stated in the release.

Reference:

www.regenexx.com.